Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
VTGN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +50.5%
VTGN
Vistagen Therapeutics, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
vistagen
therapeutics
class
action
investors
securities
trial
lawsuit
deadline
2025
march
december
2026
fasedienol
lead
firm
against
filed
palisade
plaintiff
StonvexStonvexStonvexStonvex